DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,040,714 | +5.2% | 12,256 | +1.8% | 2.24% | +8.6% |
| Q2 2023 | $2,890,320 | +87831.9% | 12,043 | -2.8% | 2.06% | -13.5% |
| Q4 2022 | $3,287 | -99.9% | 12,384 | +2.1% | 2.39% | -15.2% |
| Q3 2022 | $3,133,000 | +1.2% | 12,129 | -0.7% | 2.81% | +9.8% |
| Q2 2022 | $3,097,000 | -13.3% | 12,219 | +0.3% | 2.56% | +3.0% |
| Q1 2022 | $3,574,000 | -6.6% | 12,185 | +4.7% | 2.49% | -3.4% |
| Q4 2021 | $3,827,000 | +7.1% | 11,633 | -0.9% | 2.58% | -5.7% |
| Q3 2021 | $3,573,000 | +12.0% | 11,738 | -1.3% | 2.73% | +12.0% |
| Q2 2021 | $3,191,000 | +22.4% | 11,891 | +2.7% | 2.44% | +12.5% |
| Q1 2021 | $2,607,000 | +2.5% | 11,582 | +1.1% | 2.17% | -3.8% |
| Q4 2020 | $2,544,000 | +1.4% | 11,452 | -1.7% | 2.26% | -11.0% |
| Q3 2020 | $2,509,000 | -81.6% | 11,651 | -84.9% | 2.53% | -18.4% |
| Q2 2020 | $13,610,000 | +27.0% | 76,955 | -0.6% | 3.11% | +8.8% |
| Q1 2020 | $10,720,000 | +331.0% | 77,455 | +378.0% | 2.86% | +13.1% |
| Q4 2019 | $2,487,000 | +9.8% | 16,204 | +3.3% | 2.52% | -4.3% |
| Q3 2019 | $2,266,000 | +0.7% | 15,686 | -0.4% | 2.64% | -0.5% |
| Q2 2019 | $2,250,000 | +14.0% | 15,747 | +5.3% | 2.65% | +7.2% |
| Q1 2019 | $1,974,000 | +28.8% | 14,952 | +0.6% | 2.47% | +24.4% |
| Q4 2018 | $1,533,000 | -5.9% | 14,864 | -0.9% | 1.99% | +5.7% |
| Q3 2018 | $1,629,000 | +10.4% | 14,994 | +0.3% | 1.88% | +9.4% |
| Q2 2018 | $1,475,000 | -26.0% | 14,949 | -26.6% | 1.72% | -24.7% |
| Q1 2018 | $1,994,000 | +5.5% | 20,367 | +0.0% | 2.28% | +11.7% |
| Q4 2017 | $1,890,000 | +6.1% | 20,361 | -2.0% | 2.04% | 0.0% |
| Q3 2017 | $1,782,000 | +0.8% | 20,780 | -0.8% | 2.04% | -1.2% |
| Q2 2017 | $1,768,000 | -0.5% | 20,956 | +0.9% | 2.07% | -2.8% |
| Q1 2017 | $1,776,000 | -77.8% | 20,765 | -79.8% | 2.13% | +9.0% |
| Q4 2016 | $7,990,000 | +404.4% | 102,645 | +407.7% | 1.95% | -4.7% |
| Q3 2016 | $1,584,000 | -19.9% | 20,216 | +3.3% | 2.05% | -23.4% |
| Q2 2016 | $1,977,000 | +7.8% | 19,577 | +1.3% | 2.68% | +3.2% |
| Q1 2016 | $1,834,000 | +10.7% | 19,332 | +8.4% | 2.59% | +11.4% |
| Q4 2015 | $1,657,000 | +18.2% | 17,838 | +8.4% | 2.33% | -3.4% |
| Q3 2015 | $1,402,000 | -0.5% | 16,458 | -0.1% | 2.41% | +4.1% |
| Q2 2015 | $1,409,000 | +7.0% | 16,468 | +6.2% | 2.31% | +11.7% |
| Q1 2015 | $1,317,000 | +63.6% | 15,508 | +65.2% | 2.07% | +73.7% |
| Q4 2014 | $805,000 | – | 9,388 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |